Clinical Trial Update: A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating OC000459 in grass pollen-induced allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• OC000459

Snippet

Sponsor: Oxagen Ltd | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED